SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?


To: flickerful who wrote (509)2/1/1998 11:38:00 PM
From: 5,17,37,5,101,...  Read Replies (1) | Respond to of 756
 
I am also impressed, not only by the explicit optimism, but also by the number of pending applications. My ballpark figure of 12 new approvals for the year was not far off. I noticed in the WSJ that Glaxo's Zorivax (herpes treatment and a big seller) is off-patent. Maybe Ivax will snag that one.
Jackson